Literature DB >> 25805570

Collateral donor artery physiology and the influence of a chronic total occlusion on fractional flow reserve.

Andrew Ladwiniec1, Michael S Cunnington2, Jennifer Rossington2, Adam N Mather2, Albert Alahmar2, Richard M Oliver2, Sukhjinder S Nijjer2, Justin E Davies2, Simon Thackray2, Farquad Alamgir2, Angela Hoye2.   

Abstract

BACKGROUND: The presence of a concomitant chronic total coronary occlusion (CTO) and a large collateral contribution might alter the fractional flow reserve (FFR) of an interrogated vessel, rendering the FFR unreliable at predicting ischemia should the CTO vessel be revascularized and potentially affecting the decision on optimal revascularization strategy. We tested the hypothesis that donor vessel FFR would significantly change after percutaneous coronary intervention of a concomitant CTO. METHODS AND
RESULTS: In consecutive patients undergoing percutaneous coronary intervention of a CTO, coronary pressure and flow velocity were measured at baseline and hyperemia in proximal and distal segments of both nontarget vessels, before and after percutaneous coronary intervention. Hemodynamics including FFR, absolute coronary flow, and the coronary flow velocity-pressure gradient relation were calculated. After successful percutaneous coronary intervention in 34 of 46 patients, FFR in the predominant donor vessel increased from 0.782 to 0.810 (difference, 0.028 [0.012 to 0.044]; P=0.001). Mean decrease in baseline donor vessel absolute flow adjusted for rate pressure product: 177.5 to 139.9 mL/min (difference -37.6 [-62.6 to -12.6]; P=0.005), mean decrease in hyperemic flow: 306.5 to 272.9 mL/min (difference, -33.5 [-58.7 to -8.3]; P=0.011). Change in predominant donor vessel FFR correlated with angiographic (%) diameter stenosis severity (r=0.44; P=0.009) and was strongly related to stenosis severity measured by the coronary flow velocity-pressure gradient relation (r=0.69; P<0.001).
CONCLUSIONS: Recanalization of a CTO results in a modest increase in the FFR of the predominant collateral donor vessel associated with a reduction in coronary flow. A larger increase in FFR is associated with greater coronary stenosis severity.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  collateral circulation; coronary artery disease; physiology; pressure

Mesh:

Year:  2015        PMID: 25805570     DOI: 10.1161/CIRCINTERVENTIONS.114.002219

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  13 in total

1.  The Diagnostic Performance of Multifunction Cardiogram (MCG) in Functional Myocardial Ischemia.

Authors:  Tetsuma Kawaji; Takeshi Kimura
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-08-06       Impact factor: 1.468

2.  Fractional Flow Reserve: Does a Cut-off Value add Value?

Authors:  Shah R Mohdnazri; Thomas R Keeble; Andrew Sp Sharp
Journal:  Interv Cardiol       Date:  2016-05

3.  Survival after percutaneous coronary intervention for chronic total occlusion.

Authors:  Aurel Toma; Michael Gick; Jan Minners; Miroslaw Ferenc; Christian Valina; Nikolaus Löffelhardt; Catherine Gebhard; Florian Riede; Franz-Josef Neumann; Heinz Joachim Buettner
Journal:  Clin Res Cardiol       Date:  2016-06-01       Impact factor: 5.460

4.  Late Survival Benefit of Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion: A 10-Year Follow-Up Study.

Authors:  Taek Kyu Park; Seung Hun Lee; Ki Hong Choi; Joo Myung Lee; Jeong Hoon Yang; Young Bin Song; Joo-Yong Hahn; Jin-Ho Choi; Hyeon-Cheol Gwon; Sang Hoon Lee; Seung-Hyuk Choi
Journal:  J Am Heart Assoc       Date:  2021-03-04       Impact factor: 5.501

Review 5.  Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion.

Authors:  Ying Shen; Feng Hua Ding; Yang Dai; Xiao Qun Wang; Rui Yan Zhang; Lin Lu; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2018-02-08       Impact factor: 9.951

6.  Donor artery stenosis interactions with diastolic blood pressure on coronary collateral flow in type 2 diabetic patients with chronic total occlusion.

Authors:  Ying Shen; Zhen Kun Yang; Jian Hu; Xiao Qun Wang; Yang Dai; Su Zhang; Rui Yan Zhang; Lin Lu; Feng Hua Ding; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2018-06-01       Impact factor: 9.951

7.  Successful revascularization versus medical therapy in diabetic patients with stable right coronary artery chronic total occlusion: a retrospective cohort study.

Authors:  Yunfeng Yan; Mingduo Zhang; Fei Yuan; Hong Liu; Di Wu; Yudong Fan; Xinjing Guo; Feng Xu; Min Zhang; Quanming Zhao; Shuzheng Lyu
Journal:  Cardiovasc Diabetol       Date:  2019-08-21       Impact factor: 9.951

8.  Impact of recanalization of chronic total occlusion on left ventricular electrical remodeling.

Authors:  Kennosuke Yamashita; Wataru Igawa; Morio Ono; Takehiko Kido; Toshitaka Okabe; Naoei Isomura; Hiroshi Araki; Masahiko Ochiai
Journal:  Pacing Clin Electrophysiol       Date:  2019-04-25       Impact factor: 1.976

9.  Early effect of percutaneous coronary intervention of non-left anterior descending artery on coronary flow velocity reserve of left anterior descending artery assessed by transthoracic Doppler echocardiography.

Authors:  Masahiro Hada; Masahiro Hoshino; Nobutaka Wakasa; Tomoyo Sugiyama; Yoshihisa Kanaji; Masao Yamaguchi; Toru Misawa; Tatsuhiro Nagamine; Kai Nogami; Yumi Yasui; Taishi Yonetsu; Tetsuo Sasano; Tsunekazu Kakuta
Journal:  PLoS One       Date:  2021-08-13       Impact factor: 3.240

10.  Prompt and consistent improvement of coronary flow velocity reserve following successful recanalization of the coronary chronic total occlusion in patients with viable myocardium.

Authors:  Milan Dobric; Branko Beleslin; Milorad Tesic; Ana Djordjevic Dikic; Sinisa Stojkovic; Vojislav Giga; Miloje Tomasevic; Ivana Jovanovic; Olga Petrovic; Jelena Rakocevic; Nikola Boskovic; Dragana Sobic Saranovic; Goran Stankovic; Vladan Vukcevic; Dejan Orlic; Dragan Simic; Milan A Nedeljkovic; Srdjan Aleksandric; Stefan Juricic; Miodrag Ostojic
Journal:  Cardiovasc Ultrasound       Date:  2020-07-21       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.